Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: V. ancillary therapy and supportive care working group report

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 4, 2006, Pages 375-396

  Couriel, Daniel ^a   Carpenter, Paul A ^b   Cutler, Corey ^c   Bolaños Meade, Javier ^d   Treister, Nathaniel S ^e   Gea Banacloche, Juan ^f   Shaughnessy, Paul ^g   Hymes, Sharon ^a   Kim, Stella ^a   Wayne, Alan S ^f   Chien, Jason W ^b   Neumann, Joyce ^a   Mitchell, Sandra ^f   Syrjala, Karen ^b   Moravec, Carina K ^b   Abramovitz, Linda ^h   Liebermann, Jerry ⁱ   Berger, Ann ^j   Gerber, Lynn ^j   Schubert, Mary ^b   Filipovich, Alexandra H ^k   Weisdorf, Daniel ^l   Schubert, Mark M ^b   Shulman, Howard ^b   Schultz, Kirk ^m   Mittelman, Barbara ⁿ   Pavletic, Steven ^f   Vogelsang, Georgia B ^d   Martin, Paul J ^b   Lee, Stephanie J ^b   Flowers, Mary E D ^b   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g TEXAS TRANSPLANT INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Fred Hutchinson Cancer Research Center   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

^k UNIVERSITY OF CINCINNATI   (United States)

^l UNIVERSITY OF MINNESOTA   (United States)

^m UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁿ NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

more..

Author keywords

Allogeneic cell transplantation; Chronic graft versus host disease; Consensus; Supportive care

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIPRURITIC AGENT; ARTIFICIAL TEAR; AVOBENZONE; BISPHOSPHONIC ACID DERIVATIVE; BRONCHODILATING AGENT; CALCINEURIN INHIBITOR; CALCIUM; CEVIMELINE; CORTICOSTEROID; CYCLOSPORIN; DOXYCYCLINE; EMOLLIENT AGENT; ESTROGEN; HYDROCORTISONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; OXYGEN; PILOCARPINE; PSORALEN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TSUKUBAENOLIDE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VARICELLA ZOSTER VACCINE; VITAMIN D;

ADJUVANT THERAPY; CHRONIC GRAFT VERSUS HOST DISEASE; COGNITIVE DEFECT; CONSENSUS DEVELOPMENT; CONTACT LENS; DRUG EFFICACY; DRUG POTENTIATION; DRY EYE; ESOPHAGUS DILATATION; EYE DISEASE; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; GYNECOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LUNG DISEASE; LUNG TRANSPLANTATION; MALIGNANT NEOPLASTIC DISEASE; MOUTH DISEASE; MOUTH HYGIENE; NEPHROTOXICITY; NEUROLOGIC DISEASE; OCCUPATIONAL THERAPY; ORAL SURGERY; OSTEOPOROSIS; PATIENT EDUCATION; PHOTOTHERAPY; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PSYCHOSOCIAL DISORDER; REVIEW; SKIN DISEASE; SPECTACLES; SYSTEMIC DISEASE; THRUSH; VAGINA RECONSTRUCTION;

ANCILLARY SERVICES, HOSPITAL; CHRONIC DISEASE; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFECTION CONTROL; MALE; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC;

EID: 33644905065     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.02.003     Document Type: Review

References (146)

1. J.D. Rizzo J.R. Wingard A. Tichelli et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation Biol Blood Marrow Transplant 12 2006 138-151
2. W. Landier S. Bhatia D.A. Eshelman et. al. Development of risk-based guidelines for pediatric cancer survivors the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline J Clin Oncol 22 2004 4979-4990
3. A.H. Filipovich D. Weisdorf S. Pavletic et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report Biol Blood Marrow Transplant 11 2005 945-956
4. T. Kitajima S. Imamura Graft-versus-host reaction enhanced by ultraviolet radiation Arch Dermatol Res 285 1993 499-501
5. G.B. Vogelsang D. Wolff V. Altomonte et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA) Bone Marrow Transplant 17 1996 1061-1067
6. U. Leiter P. Kaskel G. Krahn et al. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease Photodermatol Photoimmunol Photomed 18 2002 183-190
7. S.R. Hymes W.L. Morison E.R. Farmer L.L. Walters P.J. Tutschka G.W. Santos Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction J Am Acad Dermatol 12 1985 30-37
8. T. Wetzig M. Sticherling J.C. Simon U. Hegenbart D. Niederwieser H.K. Al-Ali Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin Bone Marrow Transplant 35 2005 515-519
9. C.D. Enk S. Elad A. Vexler J. Kapelushnik R. Gorodetsky M. Kirschbaum Chronic graft-versus-host disease treated with UVB phototherapy Bone Marrow Transplant 22 1998 1179-1183
10. M. Grundmann-Kollmann H. Martin R. Ludwig et al. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease Transplantation 74 2002 1631-1634
11. S. Elad R. Or I. Resnick M.Y. Shapira Topical tacrolimus - a novel treatment alternative for cutaneous chronic graft-versus-host disease Transpl Int 16 2003 665-670
12. M. Ziemer B. Gruhn J.J. Thiele P. Elsner Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus J Am Acad Dermatol 50 2004 946-948
13. A.P.S. Smith C.E. Fife Advanced therapeutics the biochemistry and biophysical basis of wound products P.J. Sheffield Wound Care Practice 2004 Best Publishing Company Flagstaff AZ 685-730
14. S.B. Woo S.J. Lee M.M. Schubert Graft-vs.-host disease Crit Rev Oral Biol Med 8 1997 201-216
15. A.B. Voute E.A. Schulten P.N. Langendijk P.J. Kostense I. van der Waal Fluocinonide in an adhesive base for treatment of oral lichen planus.A double-blind, placebo-controlled clinical study Oral Surg Oral Med Oral Pathol 75 1993 181-185
16. D. Wolff V. Anders R. Corio et. al. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease Photodermatol Photoimmunol Photomed 20 2004 184-190
17. A. Eckardt O. Starke M. Stadler C. Reuter B. Hertenstein Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: Highly effective treatment with topical tacrolimus Oral Oncol 40 2004 811-814
18. A.R. Sanchez P.J. Sheridan R.S. Rogers Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: A case report J Periodontol 75 2004 613-619
19. J. Nemunaitis J.W. Singer C.D. Buckner et al. Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation Blood 76 1990 245-253
20. R. Nagler Y. Marmary Y. Krausz R. Chisin A. Markitziu A. Nagler Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD) Bone Marrow Transplant 17 1996 219-224
21. M.M. Schubert K.M. Sullivan T.H. Morton et al. Oral manifestations of chronic graft-v-host disease Arch Intern Med 144 1984 1591-1595
22. O. Nicolatou-Galitis V. Kitra C. Van Vliet-Constantinidou et al. The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients J Oral Pathol Med 30 2001 148-153
23. N. Treister S. Woo L.E. Lehmann E. O'Holleran S. Parsons E. Guinan Oral chronic graft-versus-host disease in pediatric patients following hematopoietic stem cell transplantation Biol Blood Marrow Transplant 11 2005 721-731
24. M.M. Schubert K.M. Sullivan Recognition, incidence, and management of oral graft-versus-host disease NCI Monogr 9 1990 135-143
25. R.M. Nagler A. Nagler Major salivary gland involvement in graft-versus-host disease considerations related to pathogenesis, the role of cytokines and therapy Cytokines Cell Mol Ther 5 1999 227-232
26. R.M. Nagler A. Nagler Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease - a prolonged study Cancer Invest 21 2003 34-40
27. A.S. Dajani K.A. Taubert W. Wilson et al. Prevention of bacterial endocarditis: Recommendations by the American Heart Association J Am Dent Assoc 128 1997 1142-1151
28. B. Calissendorff M. el Azazi B. Lonnqvist Dry eye syndrome in long-term follow-up of bone marrow transplanted patients Bone Marrow Transplant 4 1989 675-678
29. M.K. Jack G.M. Jack G.E. Sale H.M. Shulman K.M. Sullivan Ocular manifestations of graft-v-host disease Arch Ophthalmol 101 1983 1080-1084
30. J.C. Hill Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis Br J Ophthalmol 73 1989 151-154
31. R. Tanei Y. Ohta S. Ishihara K. Katsuoka H. Yokono T. Motoori Transfusion-associated graft-versus-host disease an in situ hybridization analysis of the infiltrating donor-derived cells in the cutaneous lesion Dermatology 199 1999 20-24
32. D.E. Hart M. Simko E. Harris How to produce moisture chamber eyeglasses for the dry eye patient J Am Optom Assoc 65 1994 517-522
33. J. Frucht-Pery E. Sagi I. Hemo P. Ever-Hadani Efficacy of doxycycline and tetracycline in ocular rosacea Am J Ophthalmol 116 1993 88-92
34. C.B. Cosar E.J. Cohen C.J. Rapuano et al. Tarsorrhaphy clinical experience from a cornea practice Cornea 20 2001 787-791
35. P. Rosenthal J.M. Cotter J. Baum Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens Am J Ophthalmol 130 2000 33-41
36. American Academy of Ophthalmology Punctal occlusion for the dry eye.Three-year revision Ophthalmology 104 1997 1521-1524
37. R. Altan-Yaycioglu E.A. Gencoglu Y.A. Akova D. Dursun F. Cengiz A. Akman Silicone versus collagen plugs for treating dry eye results of a prospective randomized trial including lacrimal scintigraphy Am J Ophthalmol 140 2005 88-93
38. C.M. Hutnik L.E. Probst Argon laser punctal therapy versus thermal cautery for the treatment of aqueous deficiency dry eye syndrome Can J Ophthalmol 33 1998 365-372
39. P. Marsh S.C. Pflugfelder Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome Ophthalmology 106 1999 811-816
40. M.R. Robinson S.S. Lee B.I. Rubin et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease Bone Marrow Transplant 33 2004 1031-1035
41. K. Sall O.D. Stevenson T.K. Mundorf B.L. Reis Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group Ophthalmology 107 2000 631-639
42. T. Kojima R. Ishida M. Dogru et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease a prospective randomized case-control study Am J Ophthalmol 139 2005 242-246
43. Y. Ogawa S. Okamoto T. Mori et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease Bone Marrow Transplant 31 2003 579-583
44. S.J. Lee G. Vogelsang A. Gilman et al. A survey of diagnosis, management, and grading of chronic GVHD Biol Blood Marrow Transplant 8 2002 32-39
45. S.L. Corson K. Sullivan F. Batzer C. August R. Storb E.D. Thomas Gynecologic manifestations of chronic graft-versus-host disease Obstet Gynecol 60 1982 488-492
46. M.A. Schubert K.M. Sullivan M.M. Schubert et al. Gynecological abnormalities following allogeneic bone marrow transplantation Bone Marrow Transplant 5 1990 425-430
47. L.B. Spiryda M.R. Laufer R.J. Soiffer J.A. Antin Graft-versus-host disease of the vulva and/or vagina diagnosis and treatment Biol Blood Marrow Transplant 9 2003 760-765
48. M. Anderson S. Kutzner R.H. Kaufman Treatment of vulvovaginal lichen planus with vaginal hydrocortisone suppositories Obstet Gynecol 100 2002 359-362
49. B. Cribier C. Frances O. Chosidow Treatment of lichen planus. An evidence-based medicine analysis of efficacy Arch Dermatol 134 1998 1521-1530
50. D.A. Jacobsohn J. Margolis J. Doherty V. Anders G.B. Vogelsang Weight loss and malnutrition in patients with chronic graft-versus-host disease Bone Marrow Transplant 29 2002 231-236
51. G. Akpek S.J. Lee M.E. Flowers et al. Performance of a new clinical grading system for chronic graft-versus-host disease: A multicenter study Blood 102 2003 802-809
52. F.R. Appelbaum Indications for bone marrow transplantation (BMT) in the treatment of acute myeloid leukemia (AML) Leukemia 7 1993 1081
53. C. Zauner W. Rabitsch B. Schneeweiss et al. Energy and substrate metabolism in patients with chronic extensive graft-versus-host disease Transplantation 71 2001 524-528
54. J.W. Chien P.J. Martin T.A. Gooley et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation Am J Respir Crit Care Med 168 2003 208-214
55. J.W. Chien P.J. Martin M.E. Flowers W.G. Nichols J.G. Clark Implications of early airflow decline after myeloablative allogeneic stem cell transplantation Bone Marrow Transplant 33 2004 759-764
56. H.A. Kerstjens P.L. Brand M.D. Hughes et al. Dutch Chronic Non-Specific Lung Disease Study Group A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease N Engl J Med 327 1992 1413-1419
57. K.M. Sullivan Immunomodulation in allogeneic marrow transplantation: Use of intravenous immune globulin to suppress acute graft-versus-host disease Clin Exp Immunol 104 suppl 1 1996 43-48
58. ATS statement: Guidelines for the six-minute walk test Am J Respir Crit Care Med 166 2002 111-117
59. G.B. Vogelsang How I treat chronic graft-versus-host disease Blood 97 2001 1196-1201
60. J.W. Chien D.K. Madtes J.G. Clark Pulmonary function testing prior to hematopoietic stem cell transplantation Bone Marrow Transplant 35 2005 429-435
61. T.D. Freudenberger D.K. Madtes J.R. Curtis P. Cummings B.E. Storer R.C. Hackman Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants Blood 102 2003 3822-3828
62. S.W. Crawford L. Fisher Predictive value of pulmonary function tests before marrow transplantation Chest 101 1992 1257-1264
63. American Thoracic Society Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update Am J Respir Crit Care Med 152 1995 2185-2198
64. R.O. Crapo A.H. Morris R.M. Gardner Reference spirometric values using techniques and equipment that meet ATS recommendations Am Rev Respir Dis 123 1981 659-664
65. K.H. Hsu D.E. Jenkins B.P. Hsi et al. Ventilatory functions of normal children and young adults-Mexican-American, white, and black. I. Spirometry J Pediatr 95 1979 14-23
66. P. Bierling C. Cordonnier P. Fromont et al. Acquired autoimmune thrombocytopenia after allogeneic bone marrow transplantation Br J Haematol 59 1985 643-646
67. A. Hartert W. Willenbacher S. Gunzelmann et al. Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT Bone Marrow Transplant 27 2001 337-340
68. Y.K. Keung E. Cobos J. Bolanos-Meade S. Issarachai A. Brideau D. Morgan Evans syndrome after autologous bone marrow transplant for recurrent Hodgkin's disease Bone Marrow Transplant 20 1997 1099-1101
69. I.F. Khouri C. Ippoliti J. Gajewski D. Przepiorka R.E. Champlin Neutropenias following allogeneic bone marrow transplantation: Response to therapy with high-dose intravenous immunoglobulin Am J Hematol 52 1996 313-315
70. G. Akpek Clinical grading in chronic graft-versus-host disease: Is it time for change? Leuk Lymphoma 43 2002 1211-1220
71. M. Daneshpouy G. Socie M. Lemann J. Rivet E. Gluckman A. Janin Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease Blood 99 2002 3033-3040
72. D. McNeel M.T. Rubio G. Damaj et al. Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation Transplantation 74 2002 1797-1800
73. A. Masumoto T. Sasao F. Yoshiba et al. [Hypereosinophilia after allogeneic bone marrow transplantation.A possible role of IL-5 overproduction by donor T-cells chronic GVHD.] Rinsho Ketsueki 38 1997 234-236
74. D.A. Jacobsohn T. Schechter R. Seshadri K. Thormann R. Duerst M. Kletzel Eosinophilia correlates with the presence or development of chronic graft-versus-host disease in children Transplantation 77 2004 1096-1100
75. H.N.S. Openshaw Neurologic Complications S.J. Forman K.G. Blume E.D. Thomas Hematopoietic Cell Transplantation 3rd ed. 2004 Blackwell Scientific Publications Malden, MA 811-823
76. M. Ma G. Barnes J. Pulliam D. Jezek R.J. Baumann J.R. Berger CNS angiitis in graft vs host disease Neurology 59 2002 1994-1997
77. C.S. Padovan A. Gerbitz P. Sostak et al. Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation Neurology 56 2001 1106-1108
78. P. Sostak C.S. Padovan T.A. Yousry G. Ledderose H.J. Kolb A. Straube Prospective evaluation of neurological complications after allogeneic bone marrow transplantation Neurology 60 2003 842-848
79. M.B. Max M. Culnane S.C. Schafer et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood Neurology 37 1987 589-596
80. S.H. Sindrup L.F. Gram K. Brosen O. Eshoj E.F. Mogensen The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms Pain 42 1990 135-144
81. M. Backonja A. Beydoun K.R. Edwards et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial JAMA 280 1998 1831-1836
82. M.B. Max S.C. Schafer M. Culnane R. Dubner R.H. Gracely Association of pain relief with drug side effects in postherpetic neuralgia: A single-dose study of clonidine, codeine, ibuprofen, and placebo Clin Pharmacol Ther 43 1988 363-371
83. A.K. Lefvert M. Bjorkholm Antibodies against the acetylcholine receptor in hematologic disorders: Implications for the development of myasthenia gravis after bone marrow grafting N Engl J Med 317 1987 170
84. D.R. Couriel G.Z. Beguelin S. Giralt et al. Chronic graft-versus-host disease manifesting as polymyositis: An uncommon presentation Bone Marrow Transplant 30 2002 543-546
85. B.A. Anderson P.V. Young W.F. Kean S.K. Ludwin P.R. Galbraith T.P. Anastassiades Polymyositis in chronic graft vs host disease. A case report Arch Neurol 39 1982 188-190
86. P. Parker N.J. Chao J. Ben-Ezra et al. Polymyositis as a manifestation of chronic graft-versus-host disease Medicine (Baltimore) 75 1996 279-285
87. V. Roy L. Ochs D. Weisdorf Late infections following allogeneic bone marrow transplantation: Suggested strategies for prophylaxis Leuk Lymphoma 26 1997 1-15
88. P.J. Martin P.A. Carpenter J.E. Sanders M.E. Flowers Diagnosis and clinical management of chronic graft-versus-host disease Int J Hematol 79 2004 221-228
89. J.R. Wingard G.B. Vogelsang H.J. Deeg Stem cell transplantation: supportive care and long-term complications Hematology (Am Soc Hematol Educ Program) 2002 422-444
90. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients MMWR Recomm Rep 49 2000 1-125
91. P.A. Haddad T.L. Repka D.J. Weisdorf Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: A case report and review of the literature Am J Med 113 2002 152-155
92. S. Kulkarni R. Powles J. Treleaven et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants Blood 95 2000 3683-3686
93. D.C. Molrine J.H. Antin E.C. Guinan et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation Blood 101 2003 831-836
94. S. Nachman S. Kim J. King et al. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection Pediatrics 112 2003 66-73
95. H. Shinefield S. Black P. Ray B. Fireman J. Schwalbe E. Lewis Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants Pediatr Infect Dis J 21 2002 182-186
96. D.J. Winston J.H. Antin S.N. Wolff et al. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation Bone Marrow Transplant 28 2001 187-196
97. C. Cordonnier S. Chevret M. Legrand et al. Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial Ann Intern Med 139 2003 8-18
98. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial N Engl J Med 319 1988 902-907
99. The National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection N Engl J Med 325 1991 73-80
100. J.F. Magny C. Bremard-Oury D. Brault et al. Intravenous immunoglobulin therapy for prevention of infection in high-risk premature infants: report of a multicenter, double-blind study Pediatrics 88 1991 437-443
101. H.L. Leather J.R. Wingard Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients which is better for whom? Curr Opin Infect Dis 15 2002 369-375
102. J.P. Souza M. Boeckh T.A. Gooley M.E. Flowers S.W. Crawford High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis Clin Infect Dis 29 1999 1467-1471
103. O. Lyytikainen T. Ruutu L. Volin et al. Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation Bone Marrow Transplant 17 1996 1057-1059
104. T.K. Marras K. Sanders J.H. Lipton H.A. Messner J. Conly C.K. Chan Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation Transpl Infect Dis 4 2002 66-74
105. T.J. Perren R.L. Powles D. Easton K. Stolle P.J. Selby Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation Am J Med 85 1988 99-101
106. Y. Kanda S. Mineishi T. Saito et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 28 2001 689-692
107. M.K.H.W. Boeckh M.E. Flowers J.D. Meyers R.A. Bowden Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo controlled study Blood 107 2006 1800-1805
108. J.H. Yoo D.G. Lee S.M. Choi et al. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea Bone Marrow Transplant 34 2004 497-504
109. M. Boeckh W. Leisenring S.R. Riddell et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity Blood 101 2003 407-414
110. V. Sintchenko G.L. Gilbert E. Coiera D. Dwyer Treat or test first? Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid test results J Clin Virol 25 2002 15-21
111. M.B. Rothberg S. Bellantonio D.N. Rose Management of influenza in adults older than 65 years of age: Cost-effectiveness of rapid testing and antiviral therapy Ann Intern Med 139 2003 321-329
112. K.S. Courneya M.R. Keats A.R. Turner Physical exercise and quality of life in cancer patients following high dose chemotherapy and autologous bone marrow transplantation Psychooncology 9 2000 127-136
113. A. Janin G. Socie A. Devergie et al. Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases Ann Intern Med 120 1994 993-998
114. F. Dimeo H. Bertz J. Finke S. Fetscher R. Mertelsmann J. Keul An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation Bone Marrow Transplant 18 1996 1157-1160
115. F.C. Dimeo R.D. Stieglitz U. Novelli-Fischer S. Fetscher J. Keul Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy Cancer 85 1999 2273-2277
116. M. Mello C. Tanaka F.L. Dulley Effects of an exercise program on muscle performance in patients undergoing allogeneic bone marrow transplantation Bone Marrow Transplant 32 2003 723-728
117. S. Castaneda L. Carmona I. Carvajal R. Arranz A. Diaz A. Garcia-Vadillo Reduction of bone mass in women after bone marrow transplantation Calcif Tissue Int 60 1997 343-347
118. A.D. Schimmer K. Mah L. Bordeleau et al. Decreased bone mineral density is common after autologous blood or marrow transplantation Bone Marrow Transplant 28 2001 387-391
119. A.D. Schimmer M.D. Minden A. Keating Osteoporosis after blood and marrow transplantation: Clinical aspects Biol Blood Marrow Transplant 6 2000 175-181
120. K. Kerschan-Schindl M. Mitterbauer W. Fureder et al. Bone metabolism in patients more than five years after bone marrow transplantation Bone Marrow Transplant 34 2004 491-496
121. M.I. Kang W.Y. Lee K.W. Oh et al. The short-term changes of bone mineral metabolism following bone marrow transplantation Bone 26 2000 275-279
122. J.M. Stern C.H. Chesnut III B. Bruemmer et al. Bone density loss during treatment of chronic GVHD Bone Marrow Transplant 17 1996 395-400
123. J.M. Stern K.M. Sullivan S.M. Ott et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study Biol Blood Marrow Transplant 7 2001 257-264
124. M.C. Chapuy P.J. Meunier Prevention and treatment of osteoporosis Aging (Milano) 7 1995 164-173
125. B. Dawson-Hughes S.S. Harris E.A. Krall G.E. Dallal Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older N Engl J Med 337 1997 670-676
126. P.D. Delmas Treatment of postmenopausal osteoporosis Lancet 359 2002 2018-2026
127. J.A. Cauley J. Robbins Z. Chen et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative randomized trial JAMA 290 2003 1729-1738
128. P.D. Delmas The use of bisphosphonates in the treatment of osteoporosis Curr Opin Rheumatol 17 2005 462-466
129. S. Chiodi S. Spinelli G. Ravera et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation Br J Haematol 110 2000 614-619
130. T.L. Kiss M. Abdolell N. Jamal M.D. Minden J.H. Lipton H.A. Messner Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation J Clin Oncol 20 2002 2334-2343
131. K.L. Syrjala M.K. Chapko P.P. Vitaliano C. Cummings K.M. Sullivan Recovery after allogeneic marrow transplantation: Prospective study of predictors of long-term physical and psychosocial functioning Bone Marrow Transplant 11 1993 319-327
132. N. Worel D. Biener P. Kalhs et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation Bone Marrow Transplant 30 2002 619-626
133. H.J. Beanlands J.H. Lipton E.A. McCay et al. Self-concept as a "BMT patient", illness intrusiveness, and engulfment in allogeneic bone marrow transplant recipients J Psychosom Res 55 2003 419-425
134. M.A. Andrykowski M.M. Bishop E.A. Hahn et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation J Clin Oncol 23 2005 599-608
135. H. Heinonen L. Volin M.A. Zevon A. Uutela C. Barrick T. Ruutu Stress among allogeneic bone marrow transplantation patients Patient Educ Couns 56 2005 62-71
136. H.J. Deeg W. Leisenring R. Storb et al. Long-term outcome after marrow transplantation for severe aplastic anemia Blood 91 1998 3637-3645
137. L. Edman J. Larsen H. Hagglund A. Gardulf Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation Eur J Cancer Care (Engl) 10 2001 124-130
138. L.M. Lesko J.S. Ostroff G.H. Mumma D.E. Mashberg J.C. Holland Long-term psychological adjustment of acute leukemia survivors: Impact of bone marrow transplantation versus conventional chemotherapy Psychosom Med 54 1992 30-47
139. M. Watson G. Buck K. Wheatley et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial Eur J Cancer 40 2004 971-978
140. M. Kopp B. Holzner V. Meraner et al. Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: A comparison with healthy controls Eur J Haematol 74 2005 304-308
141. J. Norris M. Kunes-Connell S.S. Spelic A grounded theory of reimaging ANS Adv Nurs Sci 20 1998 1-12
142. C.S. Neitzert P. Ritvo J. Dancey K. Weiser C. Murray J. Avery The psychosocial impact of bone marrow transplantation: A review of the literature Bone Marrow Transplant 22 1998 409-422
143. V. Mock Fatigue management: Evidence and guidelines for practice Cancer 92 2001 1699-1707
144. J.K. Payne A neuroendocrine-based regulatory fatigue model Biol Res Nurs 6 2004 141-150
145. M.J. Hjermstad H. Knobel L. Brinch et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation Bone Marrow Transplant 34 2004 257-266
146. H.J. Sutherland G.M. Fyles G. Adams et al. Quality of life following bone marrow transplantation: A comparison of patient reports with population norms Bone Marrow Transplant 19 1997 1129-1136